Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
Clinical trial NCT01811576 · COMPLETED
Trial details
- NCT number
- NCT01811576
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-31
- Primary completion
- 2013-08-05
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.